| Name | Title | Contact Details |
|---|
We are dedicated to delivering excellent customer service as we build and maintain an environment that balances the needs of our valued employees and the organization. Our development of policies, programs, and services will promote accountability, involvement, diversity, and high performance, while ensuring compliance.
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed. The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates. KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts.
Juvenon Inc is a Orinda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hinge Health is pioneering the world`s most patient-centered Digital Musculoskeletal (MSK) Clinic™. Four in five employers and 90% of health plans with a digital MSK solution have chosen Hinge Health. Hinge Health reduces MSK pain, opioid use, and surgeries by pairing advanced wearable sensors and computer vision technology with a comprehensive Clinical Care Team with doctors of physical therapy, physicians, board-certified health coaches, and more. Hinge Health`s Digital MSK Clinic is connected with 750,000+ in-person providers and enables real-time interventions for proven medical claims reduction. Available to millions of members, Hinge Health is the #1 Digital MSK Clinic with 500+ health plans and employers customers, including Boeing, Salesforce, and US Foods. Hinge Health has raised $826M to date with offices across San Francisco, Austin, Chicago, Denver, Minneapolis, Portland, Seattle and more.
Senomyx is using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients. These include modifiers of Sweet and Salt flavors as well as Savory Flavors, Bitter Blockers, and Cooling Agents. The Company is also engaged in an effort to discover and develop natural high-potency sweeteners. Under its direct sales program, Senomyx is beginning to sell certain of its Complimyx brand flavor ingredients, Sweetmyx, Savorymyx, and Bittermyx, to flavor companies for re-sale to their food and beverage company customers. In addition, Senomyx has collaborative agreements with global food, beverage, and ingredient supply companies, some of which are currently marketing products that contain Senomyx's flavor ingredients.